Comprehensive Notes on Glucocortidoids, Glucose Metabolism, and Fatty Acid Synthesis

Adrenal Glands and Cortisol Production

  • Organ Source of Cortisol: Cortisol is produced by the adrenal glands, which are located on top of the kidneys.
  • Specific Glandular Location: Within the adrenal gland, cortisol is synthesized in the adrenal cortex.
  • The Zona Fasciculata: This represents the most dense part of the adrenal cortex and is specifically responsible for the synthesis of cortisol.
  • Cortisol Classification and Function: Cortisol is categorized as a glucocorticoid. Its primary metabolic role is to raise blood glucose levels during stress or fasting.

Glucose Dynamics and Insulin Activation

  • Metabolic Conditions: Under high-power conditions (post-prandial or high-energy states), insulin is activated.
  • Insulin Action on Glucose Uptake: Insulin promotes the increased uptake and retention of glucose in cells through the activity of glucose transporters (GLUTs).
  • Activation of Glucokinase: Insulin signaling leads to the activation of glucokinase (GKGK), which catalyzes the phosphorylation of glucose in the liver.
  • Clinical Research Case Study:
        * Study Population: An experiment followed 4040 females between the ages of 2020 and 3030.
        * Subject Profile: The subjects were of normal weight with no history of diabetes.
        * Methodology: Serial blood samples were taken to monitor metabolic changes after eating.
        * Observations: Consumption of food caused a rapid rise in blood glucose followed by a subsequent drop due to a massive spike in insulin production.

Triglyceride and Fat Synthesis

  • Definition of Triglycerides: Triglycerides are also referred to as triacylglycerols. These terms describe the same substance, which is the chemical form of fat produced by the liver.
  • Synthesis Triggers: When individual glucose levels rise after eating, there is an immediate surge in fat synthesis, followed by a drop, and then another jump as glucose is processed.
  • Liver Function: The visceral liver is responsible for "cranking out" fat. A high intake of glucose leads to significant fat production.
  • Glucose vs. Fructose in Fat Synthesis: Consuming fructose leads to approximately double the amount of fat synthesis compared to the same amount of glucose.
  • PP2A Regulation: Protein Phosphatase 2A2A (PP2APP2A) is heavily involved in the regulation of fat synthesis, specifically modulating the action between different metabolic states.
  • VLDLs: The liver packages these newly synthesized fats into Very Low-Density Lipoproteins (VLDLsVLDLs) for transport in the bloodstream.

Glucokinase and Phosphofructokinase-2 Interaction

  • Glucokinase Binding: Glucokinase (GKGK) binds to the unphosphorylated form of Phosphofructokinase-2 (PFK2PFK2).
  • Primary Function of PFK2: The main metabolic role of PFK2PFK2 is the production of fructose 2,62,6-bisphosphate (F2,6BPF2,6BP).
  • Accessory Function of PFK2: PFK2PFK2 serves as a structural platform that changes the conformational state of glucokinase. It transitions GKGK from a "wide open" parallel state to a "closed" state (similar to a venus flytrap) to facilitate catalysis.
  • Structural Mechanics:
        * PFK2PFK2 possesses an arginine residue that makes contact with the GKGK molecule.
        * When PFK2PFK2 is in its dephosphorylated state, it binds to the bottom part of the GKGK hills to angle them for closure.
  • Pentose Phosphate Pathway (PPPPPP): The cellular decision to drive glucose into the PPPPPP is specifically influenced by the levels of glucose 66-phosphate (G6PG6P) and the regulatory action of fructose 2,62,6-bisphosphate.

Fructose Metabolism Challenges

  • Fructose Transport: Fructose enters the cell through the GLUT2 transporter.
  • Enzymatic Constraints: Fructose 11-phosphate cannot be directly converted into fructose 66-phosphate. There is no known enzyme in human metabolism capable of this specific conversion.
  • Path of Glycolysis: To proceed through the standard glycolytic pathway involving PFK1PFK1 and PFK2PFK2, the substrate must be in the form of fructose 66-phosphate or glucose 66-phosphate.
  • Fructose Downstream Effects: Fructose metabolism primarily drives glycolysis and the production of pyruvate, leading to citrate production, acetyl CoAs, and malonyl CoAs. However, because it bypasses major regulatory steps (like the G6PG6P to F6PF6P isomerization), it fails to provide the necessary reduction equivalents at specific steps during fatty acid synthesis.

Phosphofructokinase-1 (PFK1PFK1) Regulation

  • Reaction Sequence: Glucose 66-phosphate undergoes an isomerase reaction to produce fructose 66-phosphate.
  • Dual Phosphate Production:
        * PFK1PFK1 produces fructose 1,61,6-bisphosphate (F1,6BPF1,6BP).
        * PFK2PFK2 produces fructose 2,62,6-bisphosphate (F2,6BPF2,6BP) specifically by attaching a phosphate to the number 22 carbon, which lacks an oxygen in its normal isomer form.
  • Tetramer Stability: Fructose 2,62,6-bisphosphate binds to a specific "neck" region on the PFK1PFK1 enzyme. This binding ties the dimers together into a highly stable tetramer.
  • Binding Sites:
        * AMP Binding Site: Promotes the assembly of subunits.
        * ATP Inhibition Site: Blocks subunit assembly and inhibits activity.
  • Kinetic Impact of Fructose 2,62,6-bisphosphate:
        * In vitro experiments show that without F2,6BPF2,6BP, PFK1PFK1 is inhibited rapidly by ATP starting at approximately 0.6mM0.6\,mM.
        * Adding as little as 0.1μM0.1\,\mu M of F2,6BPF2,6BP (a 10,00010,000-fold lower concentration than the ATP inhibition threshold) protects the enzyme from ATP inhibition.
        * At 1μM1\,\mu M of F2,6BPF2,6BP, the enzyme becomes hyperactive, maintaining high activity even in high-ATP environments, which is necessary for fat synthesis in a high-energy state.

The Citrate Shuttle and Mitochondrial Processes

  • Pyruvate Fates: Pyruvate enters the mitochondria where it is processed by two main enzymes:
        1. Pyruvate Dehydrogenase (PDHPDH): Produces Acetyl CoA for the Citric Acid Cycle (TCATCA).
        2. Pyruvate Carboxylase (PCPC): Produces oxaloacetic acid (OAAOAA).
  • Citrate Lyase: Citrate is exported out of the mitochondria into the cytoplasm where Citrate Lyase breaks it back down into Acetyl CoA and oxaloacetic acid.
  • The Malic Enzyme Pathway:
        * OAAOAA in the cytoplasm is converted to malate via reduction.
        * Malic Enzyme Function: Malic enzyme oxidizes and decarboxylates malate, removing the number 44 carbon as CO2CO_2 and producing pyruvate and NADPHNADPH.
        * Reducing Power: The electrons captured in NADPHNADPH are critical for the reduction steps in fatty acid synthesis.
  • NAD+ Restoration: This cycle restores the NAD+NAD^+ required for the action of Glyceraldehyde 33-phosphate dehydrogenase (GAPDHGAPDH), ensuring glycolysis continues during active fat synthesis.

Fatty Acid Synthesis (De Novo Lipogenesis)

  • Substrate Activation: Acetyl CoA (22 carbons) is carboxylated to Malonyl CoA (33 carbons).
  • Acetyl CoA Carboxylase (ACCACC): This enzyme uses Biotin, which is attached to a lysine residue, to activate the carbon for addition to the fatty acid chain.
  • Acyl Carrier Protein (ACPACP): Malonyl CoA and Acetyl CoA are attached to sulfur groups on acyl carrier proteins during the synthesis process.
  • The Priming Step: Fatty acid synthesis is primed by exactly one molecule of Acetyl CoA.
  • Beta-Reductions: The process is essentially the reverse of beta-oxidation. It involves a series of reductions using NADPHNADPH to convert a keto group into a fully saturated carbon chain.
  • Product of Synthesis: The main product of the fatty acid synthase complex is palmitate, a 1616-carbon saturated fatty acid (16:016:0).

Post-Synthesis Modification and Regulation

  • Elongation: Palmitate is lengthened in the endoplasmic reticulum (ERER) to create stearate, an 1818-carbon chain (18:018:0).
  • Desaturation: The ERER contains desaturase enzymes that introduce double bonds. For example, stearate (18:018:0) is converted to oleate (18:118:1).
  • Regulation of Beta-Oxidation:
        * Malonyl CoA, a key intermediate in synthesis, acts as a potent inhibitor of Carnitine Palmitoyltransferase (Carnitine Translocase).
        * This inhibition prevents the newly made fatty acids from being transported into the mitochondria for oxidation, thereby avoiding a "futile cycle" where fats are synthesized and broken down at the same time.